- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
October 27, 2021
On Wednesday, October 27th, we held a webinar to discuss the state of global HIV cure investment and how Martin Delaney Collaboratory (MDC) is making investments in cure research and working with communities. The webinar featured the growing investment in both the science and stakeholder engagement of HIV cure and included an overview of the HIV cure research funding landscape, a history of the MDC program and a panel discussion.
Speakers and Panelists
Speakers:
- Kevin Fisher, AVAC
- Karl Salzwedel, NIAID
Panel Moderator:
- Jessica Salzwedel, AVAC
Panelists:
- Dixon Diallo, SisterLove President & ERASE-HIV Community Partner (US)
- Dr. Deanna Kulpa, ERASE-HIV PI (US)
- Josephine Nabukenya, EGPAF & IAS-AVAC HIV Cure Fellow (Uganda)
Recording and Slides: YouTube / Kevin Fisher's Slides / Karl Salzwedel's Slides